{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T07:44:59Z","timestamp":1707983099713},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The events that occur prior to the onset of rheumatoid arthritis (RA) continue to be delineated. We examined the relationship between self-reported joint symptoms, functional disability, and anticitrullinated protein antibody (ACPA) status in a cohort of first-degree relatives (FDR) of patients with RA who are at risk of future disease development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We studied a cohort of 279 FDR of First Nations (FN) patients with RA who are at increased risk for future RA development, and analyzed data collected at their enrollment study visit. In parallel, we analyzed data from 279 FN subjects with no family history of RA. A subset of FDR developed inflammatory arthritis and we analyzed longitudinal data in this group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of joint symptoms and functional disability was higher in FDR compared to non-FDR (all <jats:italic>P<\/jats:italic> &lt; 0.001). Difficulty walking (37.3% vs 18.0%) and modified Health Assessment Questionnaire (HAQ) results were higher in ACPA-positive FDR compared to ACPA-negative FDR, and HAQ was independently associated with ACPA seropositivity (OR 2.79, 95% CI 1.56\u20135.00). Longitudinally, in individuals who developed ACPA-positive RA, ACPA level and HAQ score were significantly associated (<jats:italic>R<\/jats:italic> = 0.45, <jats:italic>P<\/jats:italic> &lt; 0.001) in the preclinical period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Compared to population-based controls, FDR have a high burden of joint symptoms and functional disability. Functional disability was most closely associated with ACPA seropositivity in the FDR, suggesting a direct role for ACPA outside of the context of clinically detectable synovitis. HAQ appears to be particularly valuable in the assessment of individuals at risk for future RA development.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.210614","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T12:25:14Z","timestamp":1635769514000},"page":"244-250","source":"Crossref","is-referenced-by-count":5,"title":["Functional Disability to Evaluate the Risk of Arthritis in First-degree Relatives of Patients With Rheumatoid Arthritis"],"prefix":"10.3899","volume":"49","author":[{"given":"Dana","family":"Wiens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Smolik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidyanand","family":"Anaparti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani S.","family":"El-Gabalawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam J.","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"2022062202300632000_49.3.244.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.6"},{"key":"2022062202300632000_49.3.244.2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035296"},{"key":"2022062202300632000_49.3.244.3","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/art.39664","article-title":"Role of anti-carbamylated protein antibodies compared to anti-citrullinated protein antibodies in Indigenous North Americans with rheumatoid arthritis, their first-degree relatives, and healthy controls","volume":"68","author":"Koppejan","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022062202300632000_49.3.244.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.34449"},{"key":"2022062202300632000_49.3.244.5","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.40880","article-title":"A prospective study of the development of inflammatory arthritis in the family members of Indigenous North American people with rheumatoid arthritis","volume":"71","author":"Tanner","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2022062202300632000_49.3.244.6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.41483","article-title":"Association of a serum protein signature with rheumatoid arthritis development","volume":"73","author":"O\u2019Neil","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2022062202300632000_49.3.244.7","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000641"},{"key":"2022062202300632000_49.3.244.8","doi-asserted-by":"crossref","first-page":"1744806917724559","DOI":"10.1177\/1744806917724559","article-title":"Immune system involvement in specific pain conditions","volume":"13","author":"Totsch","year":"2017","journal-title":"Mol Pain"},{"key":"2022062202300632000_49.3.244.9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208094"},{"key":"2022062202300632000_49.3.244.10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181657"},{"key":"2022062202300632000_49.3.244.11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-021-02593-w","article-title":"Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) cohort","volume":"23","author":"Costello","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2022062202300632000_49.3.244.12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RHU.0000000000001006","article-title":"Prevalence and incidence of rheumatoid arthritis in Canadian First Nations and non-First Nations people: a population-based study","volume":"26","author":"Hitchon","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"2022062202300632000_49.3.244.13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1076"},{"key":"2022062202300632000_49.3.244.14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121016"},{"key":"2022062202300632000_49.3.244.15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.143560"},{"key":"2022062202300632000_49.3.244.16","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.329"},{"key":"2022062202300632000_49.3.244.17","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199209000-00009"},{"key":"2022062202300632000_49.3.244.18","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.41402","article-title":"Third-generation anti-cyclic citrullinated peptide antibodies improve prediction of clinical arthritis in individuals at risk of rheumatoid arthritis","volume":"72","author":"Di Matteo","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022062202300632000_49.3.244.19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.clinthera.2019.04.035","article-title":"Rheumatoid arthritis prevention: challenges and opportunities to change the paradigm of disease management","volume":"41","author":"Deane","year":"2019","journal-title":"Clin Ther"},{"key":"2022062202300632000_49.3.244.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.27638"},{"key":"2022062202300632000_49.3.244.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.27533"},{"key":"2022062202300632000_49.3.244.22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217066"},{"key":"2022062202300632000_49.3.244.23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/acr.23820","article-title":"Impact of cyclic citrullinated peptide antibody level on progression to rheumatoid arthritis in clinically tested cyclic citrullinated peptide antibody-positive patients without rheumatoid arthritis","volume":"71","author":"Ford","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2022062202300632000_49.3.244.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202127"},{"key":"2022062202300632000_49.3.244.25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209846"},{"key":"2022062202300632000_49.3.244.26","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/rheumatology\/kex324","article-title":"Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"56","author":"Burgers","year":"2017","journal-title":"Rheumatology"},{"key":"2022062202300632000_49.3.244.27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-019-04855-0","article-title":"EULAR definition of \u201carthralgia suspicious for progression to rheumatoid arthritis\u201d in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound","volume":"39","author":"Ruta","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2022062202300632000_49.3.244.28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-020-2102-9","article-title":"Improvement of symptoms in clinically suspect arthralgia and resolution of subclinical joint inflammation: a longitudinal study in patients that did not progress to clinical arthritis","volume":"22","author":"Ten Brinck","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022062202300632000_49.3.244.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217215"},{"key":"2022062202300632000_49.3.244.30","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1007\/s10067-020-05029-z","article-title":"High frequency of rheumatic regional pain syndromes in first-degree relatives of patients with rheumatoid arthritis","volume":"39","author":"P\u00e9rez-Barbosa","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2022062202300632000_49.3.244.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010555"},{"key":"2022062202300632000_49.3.244.32","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1097\/j.pain.0000000000001874","article-title":"Pain, nicotine, and tobacco smoking: current state of the science","volume":"161","author":"LaRowe","year":"2020","journal-title":"Pain"},{"key":"2022062202300632000_49.3.244.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.09.004"},{"key":"2022062202300632000_49.3.244.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.210614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T09:32:04Z","timestamp":1655890324000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.210614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,1]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.3899\/jrheum.210614"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.210614","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}